Gaboxadol

From Self-sufficiency
Revision as of 15:44, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Gaboxadol
File:Gaboxadol.svg
Systematic (IUPAC) name
4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3(2H)-one
Identifiers
CAS Number 64603-91-4
ATC code none
PubChem CID 3448
Chemical data
Formula C6H8N2O2
Molar mass 140.14 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Gaboxadol is an experimental sleep aid drug developed by Lundbeck and Merck. In March, 2007, Merck and H. Lundbeck cancelled work on the drug, citing safety concerns and the failure of an efficacy trial. It acts on the GABA system, but in a very different way from benzodiazepines and Z-drugs (zolpidem, zaleplon, etc).{{fact} Lundbeck states that gaboxadol also increases deep sleep (stage 4).

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links



ru:Габоксадол